Expression and Activity of Transglutaminase II in Spontaneous Tumours of Dogs and Cats

Journal of Comparative Pathology

Volumn 134, Issue 2-3, 2006, Pages 202-210

  Wakshlag, J J ^a   McNeill, C J ^a   Antonyak, M A ^a   Boehm, J E ^a   Fuji, R ^a   Balkman, C E ^a   Zgola, M ^a   Cerione, R A ^a   Page, R L ^a  

^a Cornell University ^*  (United States)

Author keywords

cat; dog; guanidine triphosphate; mammary carcinoma; transglutaminase II; tumour

Indexed keywords

DOXORUBICIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADRENAL GLAND; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLADDER; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER CLASSIFICATION; CAT DISEASE; CELL VIABILITY; CONTROLLED STUDY; DOG DISEASE; ENZYME ACTIVITY; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA; CATS; CELL LINE, TUMOR; CELL SURVIVAL; DOGS; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GTP-BINDING PROTEINS; HYPERPLASIA; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; RETROSPECTIVE STUDIES; TRANSGLUTAMINASES;

ANIMALIA; CANIS FAMILIARIS; FELIDAE;

EID: 33645861961     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2005.11.001     Document Type: Article

References (54)

1. Aeschlimann D., Kaupp O., and Paulsson M. Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate. Journal of Cell Biology 129 (1995) 881-892
2. Aeschlimann D., Mosher D., and Paulsson M. Tissue transglutaminase and factor XIII in cartilage and bone remodeling. Seminars in Thromboembolism and Hemostasis 22 (1996) 437-443
3. Aeschlimann D., and Paulsson M. Transglutaminases: protein cross-linking enzymes in tissues and body fluids. Seminars in Thromboembolism and Haemostasis 71 (1994) 402-415
4. Antonyak M.A., McNeill C.J., Wakshlag J.J., Boehm J.E., and Cerione R.A. Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells. Journal of Biological Chemistry 278 (2003) 15859-15866
5. Antonyak M.A., Miller A.M., Jansen J.M., Boehm J.E., Balkman C.E., Wakshlag J.J., Page R.L., and Cerione R.A. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibits doxorubicin-induced apoptosis in human breast cancer cells. Journal of Biological Chemistry 279 (2004) 41461-41467
6. Antonyak M.A., Singh U.S., Lee D.A., Boehm J.E., Combs C., Zgola M.M., Page R.L., and Cerione R.A. Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. Journal of Biological Chemistry 276 (2001) 33582-33587
7. Birckbichler P.J., and Patterson Jr. M.K. Cellular transglutaminase, growth, and transformation. Annals of the New York Academy of Sciences 312 (1978) 354-365
8. Boehm J.E., Singh U., Combs C., Antonyak M.A., and Cerione R.A. Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. Journal of Biological Chemistry 277 (2002) 20127-20130
9. Byrd J.C., and Lichti U. Two types of transglutaminase in the PC12 pheochromocytoma cell line. Stimulation by sodium butyrate. Journal of Biological Chemistry 262 (1987) 11699-11705
10. Chen J.S., and Mehta K. Tissue transglutaminase: an enzyme with a split personality. International Journal of Cellular and Molecular Biology 31 (1999) 817-836
11. Dadabay C.Y., and Pike L.J. Rapid increases in the transglutaminase activity of A431 cells following treatment with epidermal growth factor. Biochemistry 26 (1987) 6587-6591
12. Davies P.J., Davies D.R., Levitzki A., Maxfield F.R., Milhaud P., Willingham M.C., and Pastan I.H. Transglutaminase is essential in receptor-mediated endocytosis of alpha 2-macroglobulin and polypeptide hormones. Nature 283 (1980) 162-167
13. De Laurenzi V., and Melino G. Gene disruption of tissue transglutaminase. Molecular Cell Biology 21 (2001) 148-155
14. Driscoll H.K., Adkins C.D., Chertow T.E., Cordle M.B., Matthews K.A., and Chertow B.S. Vitamin A stimulation of insulin secretion: effects on transglutaminase mRNA and activity using rat islets and insulin-secreting cells. Pancreas 15 (1997) 69-77
15. Fesus L. Transglutaminase-catalyzed protein cross-linking in the molecular program of apoptosis and its relationship to neuronal processes. Cell and Molecular Neurobiology 18 (1998) 683-694
16. Folk J.E. Transglutaminases. Annual Reviews in Biochemistry 49 (1980) 517-531
17. Folk J.E., and Finlayson J.B. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Advances in Protein Chemistry 31 (1977) 127-133
18. Gaudry C.A., Verderio E., Aeschlimann A., Cox A., Smith C., and Griffin M. Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain. Journal of Biological Chemistry 274 (1999) 30707-30714
19. Gaudry C.A., Verderio E., Jones R.A., Smith C., and Griffin M. Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin. Experimental Cell Research 252 (1991) 104-113
20. Gentile V., Thomazy A., Piacentini M., Fesus L., and Davies P.L. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. Journal of Cell Biology 119 (1992) 463-474
21. Greenberg C.S., Birckbichler P.J., and Rice R.H. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB Journal 5 (1991) 3071-3077
22. Haroon Z.A., Hettash J.M., Lai T.S., Dewhirst M.W., and Greenberg C.S. Tissue transglutaminase is expressed, active, and directly involved in rat wound healing and anglogenesis. FASEB Journal 13 (1999) 1787-1795
23. Hettasch J.M., Bandarenko N., Burchette J.L., Lai T.S., Marks J.R., Haroon Z.A., Peters K., Dewhirst M.W., Iglehart J.D., and Greenberg C.S. Tissue transglutaminase expression in human breast cancer. Laboratory Investigation 75 (1996) 637-645
24. Johnson G.V., Cox T.M., Lockhart J.P., Zinnerman M.D., Miller M.L., and Powers R.E. Transglutaminase activity is increased in Alzheimer's disease brain. Brain Research 751 (1997) 323-329
25. Kahlem P., Green H., and Djian P. Transglutaminase action imitates Huntington's disease: selective polymerization of Huntington containing expanded polyglutamine. Molecular Cell 1 (1998) 595-601
26. Kahlem P., Green H., and Djian P. Transglutaminase as the agent of neurodegenerative diseases due to polyglutamine expansion. Pathological Biology (Paris) 46 (1998) 681-682
27. Kim H.C., Idler W.W., Kim I.G., Han H.S., Chung S.I., and Steinert P.M. The complete amino acid sequence of the human transglutaminase K enzyme deduced from the nucleic acid sequences of cDNA clones. Journal of Biological Chemistry 266 (1991) 536-539
28. Kim H.C., Lewis M.S., Gorman J.J., Park S.C., Girard J.E., Folk J.E., and Chung S.I. Protransglutaminase E from guinea pig skin. Isolation and partial characterization. Journal of Biological Chemistry 265 (1990) 21971-21978
29. Korner G., Schneider D.E., Purdon M.A., and Bjornsson T.D. Bovine aortic endothelial cell transglutaminase. Enzyme characterization and regulation of activity. Biochemistry Journal 262 (1989) 633-641
30. Lesort M., Attanavanich K., Zhang J., and Johnson G.V. Distinct nuclear localization and activity of tissue transglutaminase. Journal of Biological Chemistry 273 (1998) 11991-11994
31. Lesort M., Tucholski J., Miller M.L., and Johnson G.V. Tissue transglutaminase: a possible role in neurodegenerative diseases. Progressive Neurobiology 61 (2000) 439-463
32. Lorand L., and Conrad S.M. Transglutaminases. Molecular and Cell Biochemistry 58 (1984) 29-35
33. Maccioni R.B., and Seeds N.W. Transglutaminase and neuronal differentiation. Molecular and Cell Biochemistry 69 (1986) 161-168
34. Martinet N., Kim H.C., Girard J.E., Nigra T.P., Strong D.H., Chung S.I., and Folk J.E. Epidermal and hair follicle transglutaminases. Partial characterization of soluble enzymes in newborn mouse skin. Journal of Biological Chemistry 263 (1988) 4236-4241
35. Mehta K. High levels of transglutaminase expression in doxorubicin-resistant human breast cancer cells. International Journal of Cancer 58 (1994) 400-406
36. Mehta K., Fok J., Miller F.R., Koul D., and Sahin A.A. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clinical Cancer Research 10 (2004) 8068-8076
37. Melino G., and Piacentini M. 'Tissue' transglutaminase in cell death: a downstream or a multifunctional upstream effector?. FEBS Letters 430 (1998) 59-63
38. Milakovic T., Tucholski J., McCoy E., and Johnson G.V. Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. Journal of Biological Chemistry 279 (2004) 8715-8722
39. Miller T.J., Phelka A.D., Tjalkens R.B., Dethloff L.A., and Philbert M.A. CI-1010 induced opening of the mitochondrial permeability transition pore precedes oxidative stress and apoptosis in SH-SY5Y neuroblastoma cells. Brain Research 963 (2003) 43-56
40. Misdorp W. Tumours of the mammary gland. In: Meuten D.J. (Ed). Tumours in Domestic Animals. 4th Edit. (2002), Iowa Press, Ames, Iowa 538-547
41. Nakaoka H., Perez D.M., Baek K.J., Das T., Husain A., Misono K., Im M.J., and Graham R.M. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264 (1994) 1593-1596
42. Nanda N., Iismaa S.E., Owens W.A., Husain A., Mackay F., and Graham R.M. Targeted inactivation of Gh/transglutaminase II. Journal of Biological Chemistry 276 (2001) 20673-20678
43. Park H., Park E.S., Lee H.S., Yun H.Y., Kwon N.S., and Baek K.J. Distinct characteristic of Galpha(h) (transglutaminase II) by compartment: GTPase and transglutaminase activities. Biochemical and Biophysical Research Communications 284 (2001) 496-500
44. Piacentini M., Annicchiarico-Petruzzelli M., Oliverio S., Piredda L., Biedler J.L., and Melino E. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. International Journal of Cancer 52 (1992) 271-278
45. Piacentini M., Ceru M.P., Dini L., Di Rao M., Piredda L., Thomazy V., Davies P.J., and Fesus L. In vivo and in vitro induction of 'tissue' transglutaminase in rat hepatocytes by retinoic acid. Biochimica Biophysica Acta 1135 (1992) 171-179
46. Piacentini M., Fesus L., Sartori C., and Ceru M.P. Retinoic acid-induced modulation of rat liver transglutaminase and total polyamines in vivo. Biochemistry Journal 253 (1988) 33-38
47. Piacentini M., Martinet N., Beninati S., and Folk J.E. Free and protein-conjugated polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid. Journal of Biological Chemistry 263 (1988) 3790-3794
48. Piacentini M., Piredda L., Starace D.T., Annicchiarico-Petruzzelli M., Mattei M., Oliverio S., Farrace M.G., and Melino G. Differential growth of N- and S-type human neuroblastoma cells xenografted into scid mice. Correlation with apoptosis. Journal of Pathology 180 (1996) 415-422
49. Piredda L., Farrace M.G., Lo Bello M., Malorni W., Melino G., Petruzzelli R., and Piacentini M. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. FASEB Journal 13 (1999) 355-364
50. Singh U.S., Erickson J.W., and Cerione R.A. Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei. Biochemistry 34 (1995) 15863-15871
51. Slife C.W., Dorsett M.D., Bouquett G.T., Register A., Taylor E., and Conroy S. Subcellular localization of a membrane-associated transglutaminase activity in rat liver. Archives of Biochemistry and Biophysics 241 (1985) 329-336
52. Upchurch H.F., Conway E., Patterson Jr. M.K., and Maxwell M.D. Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme. Journal of Cell Physiology 149 (1991) 375-382
53. Wolfe L.G., Smith B.B., Kinnucan M.A., Sartin E.A., Kwapien R.P., Henderson R.A., and Barnes S. Biologic properties of cell lines derived from canine mammary carcinomas. Journal of the National Cancer Institute 77 (1986) 783-792
54. Zhang R., Tremblay T.L., McDermid A., Thibault P., and Stanimirovic D. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia 42 (2003) 194-208